NEW YORK, Aug. 21 (GenomeWeb News) - A new in vitro diagnostics company created by the authors of two important breast-cancer studies will use Agilent Technologies' microarray platform in its cancer research, the firms said today.
Registering provides access to this and other free content.
Already have an account?Login Now.
CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.
Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.
Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.
In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.